Science At BMS

Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below:

[Science At BMS @ScienceAtBMS]

Don’t miss our session at #EULAR2026, where CAR T experts will discuss the emerging research in “immune reset” concept, and key considerations for B cell–targeted strategies, including patient selection in clinical trials. https://t.co/zdys5jrZ02

[Science At BMS @ScienceAtBMS]

Join us at #EULAR2026, as we present new data from our translational research on the correlation between the tyrosine kinase 2 (TYK2) immune pathway and Sjögren’s disease manifestations. Learn more about immune signaling pathways: https://t.co/gmxxLaD3s0

[Science At BMS @ScienceAtBMS]

See how we’re advancing targeted protein degradation using three powerful approaches, CELMoD agents, ligand-directed degraders and degrader antibody conjugates, to drive innovation in cancer and beyond: https://t.co/PdvvVw9lbd

#ASCO26 #OneBMS

[Science At BMS @ScienceAtBMS]

Join us at #ASCO26 as new Phase 3 data in triple-negative breast cancer (TNBC) is presented. Learn more: https://t.co/UEtJxT222d

[Science At BMS @ScienceAtBMS]

Today at #ASCO26, tune in for results from a large real-world study on the #CART treatment experience for 2L+ #LBCL across FACT and non-FACT centers in the United States.

Share your perspective on bringing CAR T closer to home for patients. https://t.co/TrnnqCza9i

[Science At BMS @ScienceAtBMS]

At #ASCO26, new Phase 3 data in metastatic esophageal squamous cell carcinoma (ESCC) will be presented. Learn more: https://t.co/VgXS4qVLKa

[Science At BMS @ScienceAtBMS]

Stress is a challenge in care. At #ASCO26, stop by our booth to experience a brief, accessible moment of stress relief with @thrive. #OneBMS

[Science At BMS @ScienceAtBMS]

Join us tomorrow at #ASCO26 as Dr. Solange Peters presents Phase 2 results from ROSETTA Lung-02. @peters_solange

Stop by or join the live stream from 1:21–1:27pm CDT. #LungCancer #BioNTech_Group

[Science At BMS @ScienceAtBMS]

Join us tomorrow at #ASCO26 as Dr. Tiago Biachi de Castria presents ROSETTA CRC-203 TiP poster. @BiachiTiago

Join the poster session from 9am to 12pm CDT. #GICancer #BioNTech_Group

[Science At BMS @ScienceAtBMS]

Breakthroughs in oncology are moving fast—but access is still determining who benefits from them.

On DoctoRx Unscripted, leading oncologists join Dr. Tania Small to explore what it will take to close that gap. Watch the full oncology series now: https://t.co/da0zAsHCVM

[Science At BMS @ScienceAtBMS]

Nearly 70% of lung cancers are still diagnosed at an advanced stage, but science is changing what’s possible—giving some patients years of life back. Two leading oncologists join Dr. Tania Small to discuss how more patients can benefit. Watch now: https://t.co/ceclspOKPC

[Science At BMS @ScienceAtBMS]

Melanoma incidence continues to rise, affecting diverse age groups. Early detection and awareness are vital for better outcomes.

Hear more about the realities of melanoma: https://t.co/23StsBLKuV

#OneBMS #MelanomaAwarenessMonth

[Science At BMS @ScienceAtBMS]

At #ATS2026, we're exploring the pathophysiology of #PulmonaryFibrosis, and the key role the lysophosphatidic acid (LPA-LPA1) pathway plays in epithelial cell injury, inflammation and fibrosis—all of which result in disease progression. Learn more: https://t.co/htgR1Bu8uQ #OneBMS

[Science At BMS @ScienceAtBMS]

Endocannabinoids help regulate neuronal signaling. We’re exploring how inhibition of Fatty acid amide hydrolase (FAAH) and Monoacylglycerol lipase (MAGL) may impact endocannabinoid levels in conditions like Alzheimer’s disease. Learn more: https://t.co/rgOtj9wb2B #OneBMS

[Science At BMS @ScienceAtBMS]

Wrap up the last day of the #AACR2026 conference by stopping by the poster session to hear Dr. Jaclyn Neely’s presentation of the biomarker analyses from the RELATIVITY 104 trial.

Join the session from 9am to 12pm PST #LungCancer #NSCLC

[Science At BMS @ScienceAtBMS]

Stop by the poster session tomorrow, at #AACR2026, to hear Dr. Takekazu Aoyama’s overview of the RELATIVITY 020 clinical trial, with a focus on dose safety and efficacy.

Join the session from 9am to 12pm PST. #SolidTumor

[Science At BMS @ScienceAtBMS]

Today at #AACR2026, Dr. Igor Katsyv will present the poster Comparison of MTAP loss by IHC and MTAP homozygous deletion by NGS and DNA FISH.

Stop by the poster session from 2–5pm PST. #CancerGenomics #AssayDevelopment #AACR2026

[Science At BMS @ScienceAtBMS]

Our teams are advancing targeted protein degradation leveraging three distinct modalities: CELMoD agents, ligand-directed degraders and degrader antibody conjugates. Explore how we’re driving cancer breakthroughs: https://t.co/sLyIwnbqEj

#AACR26 #ScienceFirsthand #OneBMS

[Science At BMS @ScienceAtBMS]

At #AACR26, Dr. Tina Cascone will present data from CheckMate 77T, exploring clinical outcomes by genomic markers and ctDNA dynamics in resectable non-small cell lung cancer (#NSCLC). Learn more: https://t.co/JctSJCnTjE

[Science At BMS @ScienceAtBMS]

Explore evidence-based management of Alzheimer’s disease psychosis at AAGP 2026. Dr. Amita Patel, MD, will discuss clinical recognition, differential diagnosis, and current and emerging therapeutic approaches.